Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Enlight Biosciences LLC

www.enlightbio.com

Latest From Enlight Biosciences LLC

JDRF, PureTech Try Nonprofit Ownership To Fill Funding Gap For Diabetes Tech

Call it venture philanthropy with a twist: If all goes as planned, the Juvenile Diabetes Research Foundation will co-own a series of companies dedicated to type 1 diabetes treatments without violating tax code, thanks to a structure created by Boston’s PureTech Ventures.

Medical Device BioPharmaceutical

JDRF, PureTech Try Nonprofit Ownership To Fill Funding Gap

Call it venture philanthropy with a twist: if all goes to plan, the Juvenile Diabetes Research Foundation will co-own a series of biotech companies dedicated to type 1 diabetes treatments without violating tax code, thanks to a structure created by Boston’s PureTech Ventures.

BioPharmaceutical Strategy

JDRF, PureTech Try Nonprofit Ownership To Fill Funding Gap

Call it venture philanthropy with a twist: if all goes to plan, the Juvenile Diabetes Research Foundation will co-own a series of biotech companies dedicated to type 1 diabetes treatments without violating tax code, thanks to a structure created by Boston’s PureTech Ventures.

BioPharmaceutical Business Strategies

BIO 2013 Tuesday Roundup: Reimbursement Reigns, Industry Innovation, New Antibodies

Our survey of news and notes from the second day of the BIO conference includes discussions of changes in the way pharma negotiates milestones, big ambitious projects to solve industry “dysfunction,” and a next-generation antibody developer pushing toward the clinic.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
    • Large Molecule
      • Antibodies
    • Pharmacogenetics-Pharmacogenomics
    • Synthesis Technologies, Production Processes
  • In Vitro Diagnostics
  • Pharmaceuticals
    • Drug Delivery
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Enlight Biosciences LLC
  • Senior Management
  • Michelle Browner, CEO
    Jonathan Behr, PhD, Project Dir.
  • Contact Info
  • Enlight Biosciences LLC
    Phone: (617) 482-2333
    500 Boylston St.
    Ste 1600
    Boston, MA 02116
    USA
UsernamePublicRestriction

Register